Islet MC4R Regulates PC1/3 to Improve Insulin Secretion in T2DM Mice via the cAMP and β-arrestin-1 Pathways
Authors:
- 28 July 2022
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 194 (12) , 6164-6178
Abstract
Melanocortin-4 receptor (MC4R) plays an important role in energy balance regulation and insulin secretion. It has been demonstrated that in the pancreas, it is expressed in islet α and β cells, wherein it is significantly correlated with insulin and glucagon-like peptide-1 (GLP-1) secretion. However, the molecular mechanism by which it regulates islet function is still unclear. Therefore, in this study, our aim was to clarify the signaling and target genes involved in the regulation of insulin and GLP-1 secretion by islet MC4R. The results obtained showed that in islet cells, the expression of prohormone convertase 1/3 (PC1/3), which is correlated with islet GLP-1 and insulin secretion, increased significantly under the action of the MC4R agonist, NDP-α-MSH, but decreased under the action of the MC4R antagonist, AgRP. Additionally, we observed that to exert their regulatory functions in the islets, cAMP and β-arrestin-1 acted as important signaling mediators of MC4R, and compared with control islets, the cAMP, PKA, and β-arrestin-1 levels corresponding to NDP-α-MSH-treated islets were significantly elevated; however, in AgRP-treated islets, their levels decreased significantly. Islets treated with the PKA inhibitor, H89, and the ERK1/2 inhibitor, PD98059, also showed significant decreases in PC1/3 expression level, indicating that the cAMP and β-arrestin-1 pathways are significantly correlated with PC1/3 expression. These findings suggest that islet MC4R possibly affects PC1/3 expression via the cAMP and β-arrestin-1 pathways to regulate GLP-1 and insulin secretion. These results provide a new theoretical basis for targeting the molecular mechanism of type 2 diabetes mellitus.Keywords
Funding Information
- Xuzhou Municipal Science and Technology Bureau (KC21273, KC21031)
This publication has 43 references indexed in Scilit:
- The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In VivoCell Metabolism, 2014
- Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed ratsMetabolism, 2014
- β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in miceDiabetologia, 2013
- β-Cell–Specific Protein Kinase A Activation Enhances the Efficiency of Glucose Control by Increasing Acute-Phase Insulin SecretionDiabetes, 2013
- Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus MacaquesDiabetes, 2013
- Melanocortin 4 Receptors Reciprocally Regulate Sympathetic and Parasympathetic Preganglionic NeuronsCell, 2013
- Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptorEndocrine, 2010
- Transplantation of PC1/3-Expressing α-cells Improves Glucose Handling and Cold Tolerance in Leptin-resistant MiceMolecular Therapy, 2009
- Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3)Diabetologia, 2008
- β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cellsProceedings of the National Academy of Sciences, 2008